Longer-term dual antiplatelet therapy with clopidogrel and aspirin prevented ischemic events without raising bleeding risk in ...

CryoTherapeutics, a medical device company developing minimally invasive localized cryotherapy for the treatment of coronary artery disease, today announced the successful treatment of the first ...

You have full access to this article via your institution. Following PCI, approximately half of the patients in each group were randomized to fluvastatin 40 mg twice daily, and the remainder received ...

Background Clinical benefit of percutaneous coronary intervention (PCI) in chronic coronary syndromes (CCS) remains ...

More than one in 10 patients with no coronary calcium had noncalcified plaque, putting them at greater risk for MACE.

A large head-to-head analysis reveals when outcomes began to diverge and why questions about the drugs’ cardiovascular effects remain unresolved. Semaglutide vs. liraglutide and incidence of diabetes ...

This snake’s toxic bite causes paralysis, which keeps its strong and speedy eel prey from escaping. Yellow-lipped sea kraits, ...

Objective To evaluate the cost-effectiveness of percutaneous coronary intervention (PCI) compared with placebo in patients with single-vessel coronary artery disease and angina despite anti-anginal ...

New clinical trials show beta-blockers offer no benefit and may raise risks for older heart attack survivors with normal heart function. The post Common Heart Drug May Be Doing More Harm Than Good in ...

Problems with the heart and blood supply were relatively rare in 1900, and are now the number one killer worldwide. Heart ...

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company"), the leading autologous (patient's own stem cells) regenerative medicine company is pleased to announce that it has filed its ...

A Midtown high-rise that suffered structural damage had not moved since Tuesday, Mayor Zohran Mamdani said. The streets around the building were starting to come back to life after a tense day.